Teleflex Incorporated (TFX)

The total asset value of Teleflex Incorporated (TFX) stood at $ 7,098 Mln as on 31-Dec-24

The share price of Teleflex Incorporated (TFX) is $129.48 (NYSE) as of 17-Apr-2025 16:10 EDT. Teleflex Incorporated (TFX) has given a return of -27.27% in the last 3 years.

Teleflex Incorporated (TFX) has a market capitalisation of $ 5,785 Mln as on 17-Apr-2025. As per Value Research classification, it is a Small Cap company.

The P/E ratio of Teleflex Incorporated (TFX) is 86.90 times as on 17-Apr-2025.

Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Teleflex Incorporated (TFX) and enter the required number of quantities and click on buy to purchase the shares of Teleflex Incorporated (TFX).

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, the measurement of blood pressure, and the collection of blood samples. The company also offers interventional products, including various coronary catheters, structural heart support devices, peripheral intervention products, and mechanical circulatory support platform; and Arrow branded intra-aortic balloon pumps and catheters, Guideliner, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway, pain management, and hemostatic products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligating clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology, as well as bladder management services; and OEM products, which includes the TFX Medical OEM, TFX OEM, Deknatel, and HPC Medical brands. It serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

The CEO & director of Mr. Liam J. Kelly. is Teleflex Incorporated (TFX), and CFO & Sr. VP is Mr. Jay White.

There is no promoter pledging in Teleflex Incorporated (TFX).

Some of the close peers are:

Yes, TTM profit after tax of Teleflex Incorporated (TFX) was $70 Mln.